Antagonism

Antagonism is the action of a molecule binding to a receptor and occupying it without triggering the downstream signal that receptor normally carries. The molecule takes up space — and blocks access — but produces no response of its own. The pharmacological term for a substance that does this is an antagonist.

This distinguishes antagonism from agonism, in which binding and activation happen together, and from partial agonism, in which binding produces a muted signal. A pure antagonist is pharmacologically silent at the receptor it occupies; its effect is defined entirely by what it prevents.

How it works · its role

Most antagonists work by competing with agonists for the same binding site on a receptor — a pattern called competitive antagonism. At higher concentrations, the antagonist outcompetes the agonist; at lower concentrations, the agonist can displace it. The balance shifts with relative concentration and affinity, which is why a high enough dose of an opioid can eventually overcome the block that naloxone places at opioid receptors.

Some antagonists bind irreversibly, or bind at a separate site that physically changes the receptor's shape so agonists can no longer fit. These non-competitive or allosteric antagonists impose a ceiling on agonist effect that more drug cannot break through, regardless of dose.

Duration matters separately from mechanism. An antagonist that stays bound longer than the substance it displaces — as naltrexone does relative to most opioids — extends its effect well beyond the body's clearance of the original drug. Whether a block outlasts what it displaces is a clinical question with direct consequences for reversal and redosing risk.

Relevance to substances & effects

Antagonism underlies several distinct families of effects in this index. Opioid antagonists — naloxone and naltrexone — reverse or block opioid effects by outcompeting opioids at mu receptors. Flumazenil does the same at benzodiazepine receptors. These reversal agents are clinically important precisely because competitive antagonism is reversible: if the antagonist clears before the agonist does, the original effects can return.

Antipsychotics exert many of their effects through dopamine receptor antagonism, particularly at D₂ receptors. This attenuates dopaminergic signalling in ways that reduce certain symptoms but can also produce movement-related side effects as an unwanted consequence of the same block.

Antihistamines act as histamine receptor antagonists and are used recreationally in some contexts at higher doses. Several psychedelic-adjacent compounds — including members of the phenethylamine and tryptamine classes — show antagonism at certain serotonin receptor subtypes alongside agonism at others, with the balance between these actions shaping their subjective profile.

Because antagonists compete for receptor sites, they sit at the center of many interaction risks catalogued across this encyclopedia. A substance taken while a long-acting antagonist is active may produce far less effect than expected; conversely, a potent agonist combined with an inhibitor that slows its metabolism may accumulate high enough to overcome a partial antagonist block.